^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

EP300 mutation

i
Other names: EP300, E1A binding protein p300, p300, KAT3B, RSTS2
Entrez ID:
Related biomarkers:
Phase 1/2
CellCentric Ltd.
Recruiting
Last update posted :
01/19/2024
Initiation :
07/23/2018
Primary completion :
03/01/2024
Completion :
03/01/2024
MYC • AR • ARID1A • CREBBP
|
ARID1A mutation • CREBBP mutation • EP300 mutation
|
Lynparza (olaparib) • Tecentriq (atezolizumab) • enzalutamide • abiraterone acetate • Nubeqa (darolutamide) • inobrodib (CCS1477)